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1. Introduction 
Immune defects in children have been shown to have profound effects on oral tissues. (Joint 
United Nations Program on HIV/AIDS [UNAIDS], 2002, 2005).  
Oral lesions are among the earliest and most common clinical sign of infection with the 
Human Immunodeficiency Virus (HIV), are important indicators and can predict 
progression of HIV infection. A number of studies have shown that oral lesions are common 
in HIV infected patients. Knowledge and awareness of the signs and symptoms, of oral 
lesions that may be indicative of the patients’ HIV status will assist in instituting the 
appropriate careful steps of management at an early stage for better prognosis. (Chadwick & 
Yogev, 1995; Eldridge & Gallagher, 2000; Fowler et al., 2000; Gray & McIntyre, 1999; Ramos-
Gomez, 1997; Sullivan, 2003; Working Group on Mother To Child Transmission of HIV, 
1995). A thorough understanding of these lesions has implications for all health care 
professionals.  
HIV progression is faster and more severe in children, due to the immaturity of the immune 
system. Most children born with HIV infection are symptomatic at birth, however time 
between birth and initial symptoms and signs varies considerably. The median age of 
paediatric patients at the time of an AIDS diagnosis is 12 months with oral manifestations 
often the first sign of infection in approximately half of all infected children. (Magalhaes et 
al, 2001; Ramos-Gomez, 1997, Ramos-Gomez et al., 2000; Rosemberg & Faucias 1994).  
Most children will develop one or more oral manifestation of HIV infection during the 
course of the disease, similar to that seen in adults. (Leao et al., 2009; UNAIDS 2002, 2004). 
AIDS has emerged as the seventh leading cause of death among infants and children in the 
United States of America (USA), and a leading cause of death among minority groups and 
in low income countries (LINCs). (Centres for Disease Control and Prevention [CDC] 1993; 
Ramos-Gomez et al., 2000; UNAIDS, 2009) 
Majority of paediatric HIV infections are the result of Mother To Child Transmission 
(MTCT). The increasing proportion of infected children achieving adulthood highlights the 
need for multidisciplinary approach to management and thus facilitates transition to adult 
care while maintaining strategies specific for mother to child acquired infections. (Giaquinto 
et al, 2010; Massarente et al 2011; Swendeman et al, 2009).  
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Evidence of HIV disease progression in both adult and paediatric patients is marked by oral 
manifestations and general periodontal status, and oral symptoms and signs may have 
prognostic value that is independent of CD4 status or other commonly used markers. 
(Greenspan & Greenspan, 1999; Ramos-Gomez et al., 2000). Oral lesions commonly 
associated with paediatric HIV infection include oral candidiasis, herpes simplex virus 
infection, linear gingival erythema and recurrent aphthous ulcers. Oral candidiasis is the 
commonest oral manifestation in children and may be associated with burning sensation in 
the mouth, problems with nutrition and changes in taste. (Orne-Glieman et al., 2008) Oral 
candidiasis has also been associated with HIV disease progression and immune system 
deterioration as evidenced by low CD4 counts in both adults and children with the 
infection. However, parotid gland enlargement is indicative of a better prognosis, with 
slower disease progression or long term survival. (Katz et al., 1993; Magalhaes et al., 2001; 
Ramos-Gomez et al., 1999) 
Recognition of these early oral signs during routine examinations and in surgical procedures 
is important for diagnosis and treatment, which allows for early intervention, clinical 
staging of the infection leading to better prognosis, reduced morbidity and improved 
quality of life in this population. The early diagnosis of these lesions will help in assessing 
disease progression especially in LINCs where limited resources hamper disease specific 
interventions. 
2. Literature review 
2.1 Epidemiology 
HIV is a global pandemic, which continues to escalate throughout developing countries 
compared to a notable stabilization in new cases and fatalities in some developed countries. 
The number of people living with HIV worldwide continued to grow in 2008, reaching an 
estimated 33. 4 million. The total number of people living with the virus in 2008 was more 
than 20% higher than the number in 2000, and the prevalence reported to be roughly 
threefold higher than in 1990. (UNAIDS, 2009). The continuing rise in the population of 
people living with HIV reflects the combined effects of continued high rates of new HIV 
infections and the beneficial impact of antiretroviral therapy. As of December 2008, 
approximately 4 million people in low- and middle-income countries were receiving 
antiretroviral therapy. An estimated 430,000 new HIV infections occurred among children 
under the age of 15 in 2008. Most of these new infections are believed to stem from 
transmission in-utero, during delivery or post-partum as a result of breastfeeding. The 
number of children newly infected with HIV in 2008 was roughly 18% lower than in 2001. 
To date, UNAIDS estimates that 40 million are living with HIV/AIDS, with more than 95% 
in developing countries, including 28. 5% in sub-Saharan Africa, and out which at least 2. 1 
million are children under the age of 15years. (Barnett & Whiteside, 2006; Greene, 2007; 
Nigeria, 1992; UNAIDS, 2002, 2004, 2005, 2006, 2009).  
Studies on oral manifestations of HIV infection have reported that these lesions are 
common, with a wide variation in the prevalence of lesions; 41% to 99. 5% prevalence 
reported in studies carried out on populations of intravenous drug abusers and other risk 
groups. (Arendorf et al., 1998; Barone et al., 1990; Ceballos-Salobrena et al., 1996; Onunu & 
Obuekwe, 2002; Sauer et al.,1995; Schimdt-Westhausen et al 1997., Ukpebor & Braimoh, 
2006; Wright, 2003). The wide variations in the prevalence of oral lesions in the literature 
have been attributed to a number of factors, and include sample randomization, sample size, 
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clinical stage at presentation, risk group, education, race, socioeconomic status and access to 
health care. Most studies have reported a high prevalence of at least one oral lesion in 
children with HIV infection, with oral candidiasis being the most prevalent oral condition. 
(Barasch et al., 2000; Glick, 2005; Katz et al., 1993; Lamster et al., 1994; Ramos-Gomez et al., 
1996; Yengopal et al., 2011).  
2.2 Pathogenesis 
The acquired immunodeficiency syndrome (AIDS) was first observed in 1981 in young male 
homosexuals in the United States of America (USA); though there are evidences that 
sporadic cases may have been in existence before then. (Olumide, 2002; Scully, 1997) The 
causative organism was identified and named as the Human Immunodeficiency Virus 
(HIV). It is a member of the lentevirus subfamily. Two strains HIV-1 and HIV-2 the primary 
aetiological viruses for AIDS were described in 1983 and 1986 respectively. However, HIV 
infection in children was first described in 1983. (Oleske et al., 1983). HIV disease in infants 
and children, as in adults, is a progressive disease with a clinical spectrum ranging from 
asymptomatic infection to profound and eventual fatal immunosuppression. AIDS is the 
point on this spectrum where significant immunodeficiency causes emergence of conditions 
that meet the criteria for the Centres for Disease Control (CDC) definition of AIDS 
diagnosis. (Ammann, 1999). The hallmark of immunodeficiency caused by HIV infection is 
the depletion of cells of the immune system: CD4+ T lymphocytes, macrophages, monocytes 
and dendritic cells that express the CD4 receptors. The gradual decrease in the number of 
cells of the immune system and the functional decline of these cells lead to the breakdown of 
the immune system, exposing infected individuals to a wide variety of viral, bacterial, 
fungal and parasitic infections as well as the development of malignancies that result in full 
blown AIDS. These conditions when occurring in the mouth constitute the oral 
manifestations of HIV/AIDS and may be indicators of HIV infection. (Agbelusi & Wright 
2005; Zijenah & Katzenstein, 2002).  
2.2.1 Transmission 
The epidemic in children has risen globally due to the worldwide increase in HIV 
prevalence in women of childbearing age. Majority of paediatric HIV/AIDS cases are as a 
result of transmission from mother to child. Though the source and route of transmission is 
multifactorial, mother to child transmission (MTCT) is the commonest mode of transmission 
of HIV in children. In the absence of any intervention, the risk of MTCT is 15–30% in non-
breastfeeding populations and 20–45% among populations who practice prolonged 
breastfeeding. It is estimated that 50% of HIV-infected infants will die before the age of two. 
(De Cock et al., 2000; Newell et al., 2004). 
Effective prevention of mother-to-child transmission involves simultaneous support for 
several strategies that work synergistically to reduce the odds that an infant will become 
infected as a result of exposure to the mother’s virus. Through the reduction in overall HIV 
among reproductive-age women and men, the reduction of unwanted pregnancies among 
HIV-positive women, the provision of antiretroviral drugs to reduce the chance of infection 
during pregnancy and delivery and appropriate treatment, care and support to mothers 
living with HIV (including infant feeding), programmes are able to reduce the chance that 
infants will become infected. In ideal conditions, the provision of antiretroviral prophylaxis 
and replacement feeding can reduce transmission from an estimated 30% to 35% with no 
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intervention to around 1% to 2%. Most countries have not yet reached all pregnant women 
with these services, let alone significantly reduced HIV prevalence among reproductive-age 
individuals or unwanted pregnancies among HIV-positive women. (Ammann 2006; 
UNAIDS 2009).  
2.3 Clinical aspect of HIV disease in children 
2.3.1 Orofacial manifestations 
The development of HIV infection in children has different characteristics to those noted in 
adults, due mainly to the earlier acquisition of the virus, combined with the immaturity of 
the immunologic system and other body structures. The clinical features of pediatric HIV 
infection includes the appearance of various oral lesions, some of which are considered 
AIDS diagnosis markers, such as recurrent oral candidiasis and chronic enlargement of the 
parotid. The most frequently associated oral lesions are: candidiasis, herpes simplex 
infection, linear gingival erythema (LGE), parotid enlargement and recurrent aphthous 
stomatitis. Other viral and bacterial infections, including periodontal infections are less 
commonly associated, while hairy leukoplakia and Kaposi's sarcoma are rarely seen in HIV-
infected children. (Greenspan D, 1998; Soares et al., 2004). The oral manifestations of HIV 
disease in adults and children were classified before the advent of anti-retroviral drugs 
(ART). Patients who do not receive ART are likely still to have the common oral features of 
HIV disease: candidiasis (typically pseudomembranous candidiasis), hairy leukoplakia, 
Kaposi's sarcoma, non-Hodgkin’s lymphoma and, perhaps periodontal disease. (Frezzini et 
al., 2006). Dry mouth as a result of decreased salivary flow rate may not only increase the 
risk of dental caries but further impact negatively on quality of life because of difficulty in 
chewing, swallowing and tasting food. According to the World Oral Health Report 2003 
priority is given to effective prevention of oral manifestations of HIV/AIDS through 
additional actions. These actions are integral components of WHO and joint United Nations 
global programs for control of HIV/AIDS. These collaborative programs include but are not 
limited to the identification of the most indicative oral manifestations of HIV/AIDS, training 
of other health professional and dissemination of information on disease prevention and 
recognition. (Petersen, 2003; 2004; UNAIDS 2004; WHO, 2003). 
2.3.2 Overview of treatment 
Anti retroviral drugs (ARDs) used in the management of HIV-infection now principally 
comprise four classes of retroviral agents: 
Nucleoside analog reverse transcriptase inhibitors (NRTIs); 
Non-nucleoside analog reverse transcriptase inhibitors (NNRTIs); 
Protease inhibitors (Pis) and Entry inhibitors.  
However, effective anti-retroviral therapies are rarely available to HIV-infected people in 
LINCs and the developing world, particularly areas of Africa. Moreover, only a handful of 
ARDs in the current WHO guidelines have solid formulations in doses appropriate for 
pediatric use and pediatric fixed-dose drug combinations are scarce.  
3. Oral manifestations in paediatric HIV infection 
3.1 Classification of oral lesions in HIV infection 
Oral lesions seen in HIV disease have been classified by the EC Clearing house on oral 
problems related to HIV infection and WHO collaborating centre on Oral manifestations of 
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the immunodeficiency virus into three main groups. (Coogan et al 2005; Greenspan JS & D, 
1995; Leao et al., 2009). These are: 
Group 1: Lesions strongly associated with HIV infection  
Group 2: Lesions less commonly associated with HIV infection 
Group 3: Lesions seen in HIV infection 
These lesions have also been grouped according to their aetiology as: 
 Neoplastic conditions 
 Bacterial infections 
 Fungal infections 
 Viral infections 
 Autoimmune disorders 
 Neurological disturbances 
 Other conditions.  
The spectrum of oral diseases in HIV infected children differs significantly from that of 
adults. These differences have been attributed to differences in the viral induced 
immunopathologic changes in these two different age groups as well as to being the result 
of decreased exposure at a young age to certain viruses, which reduces the risk for diseases 
such as oral hairy leukoplakia, oral warts, Kaposi’s sarcoma and lymphoma. Despite this 
limited range of diseases, most children will develop one or more oral manifestation of HIV 
infection during the course of the disease, similar to that seen in adults Orofacial 
manifestations of paediatric HIV infection have been divided into four groups. (Flaitz 
&Hicks, 2003; Fonseca et al., 2000). 
3.1.1 Oral lesions commonly associated with paediatric HIV infection 
 Candidiasis- 
Pseudomembranous 
Erythematous 
Angular cheilitis 
 Herpes simplex viral infection 
 Linear gingival erythema 
 Major salivary gland enlargement 
 Recurrent aphthous ulcers- 
Minor, major, and herpetiform 
3.1.2 Oral lesions less commonly associated with paediatric HIV infection 
 Bacterial infections 
 Periodontal diseases 
 Necrotizing ulcerative gingivitis (NUG) 
 Necrotizing ulcerative periodontitis (NUP) 
 Necrotizing stomatitis (NS) 
 Viral infections (cytomegalovirus, human papilloma virus, varicella zoster virus, 
molluscum contagiosum) 
 Xerostomia 
3.1.3 Oral lesions strongly associated with HIV infection but rare in children 
 Kaposi’s sarcoma 
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 Non-Hodgkin’s lymphoma 
 Oral hairy leukoplakia 
 Tuberculosis-related ulcers 
3.1.4 Oral conditions with increased severity in paediatric HIV infection 
 Gingivitis and periodontitis (increased gingival and plaque indices) 
 Over-retained primary teeth 
 Delayed eruption of primary and permanent teeth 
 Primary dentition caries 
4. Oral lesions commonly associated with paediatric HIV infection  
4.1 Oral candidiasis 
This is the most common oral soft tissue manifestation of paediatric HIV infection. (Barasch 
et al., 2000; Fonseca et al 2000; Kline 1996; Ramos-Gomez et al., 1999). Candidiasis is often 
the first clinically observable manifestation of HIV infection, with up to 72% of these 
children developing the disease. (Flaitz & Hicks 2003).  
Candidiasis has been reported as the commonest oral lesion in several studies and has been 
used as a clinical marker of the disease as the frequency of oral candidiasis usually 
correlates with a falling CD4+ T lymphocyte count and a rising HIV viral load 
Pseudomembranous candidiasis remains the commonest variant, followed by erythymatous 
candidiasis and angular cheilitis. Studies indicate that oral candidiasis is prevalent in 
HIV/AIDS and has been reported in up to 72% of all pediatric HIV infection. (Flaitz & Hicks 
2003; Kline 1996; Naidoo & Chikte 2004; Obileye 2006; Olaniyi & Sunday 2005; Ramos-
Gomez et al 1999; Sowole et al., 2009). However, oral pseudo-membranous candidiasis is not 
uncommon in healthy infants in the first six months of life. However, in immuno-competent 
children, Candida lesions are often mild, readily amenable to treatment, or regress 
spontaneously and are rarely seen beyond infancy in the absence of predisposing factors. In 
addition, concurrent oral infection is the most common clinical presentation of oesophageal 
candidiasis, a very debilitating and symptomatic AIDS-defining condition in children. 
(Chiou et al., 2000) Candida albicans was the primary aetiological agent but recently other 
species including C. tropicalis, C. krusei, C. glabrata, C. parasilosis, C. pseudotropicalis, C. 
gulliermondi, have been identified. C. dubliniensis, a newly emerging pathogen. isolated 
almost exclusively in HIV infected and oncology patients has been identified. (Brown et al 
2000).  
Clinical features of candidiasis are variable depending on the form of the disease. The 
different forms associated with HIV  
infection are: 
4.1.1 Pseudomembraneous candidiasis or thrush 
This presents as non-adherent multifocal, creamy white to yellow papules or plaques 
overlying the oral mucosa. Removal of this material often leaves an erythematous mucosal 
surface, which occasionally bleeds. It typically occurs on the buccal mucosa, mucobuccal 
folds, dorsolateral tongue and the oropharynx, but may occur throughout the 
oropharyngeal region. (Flaitz & Hicks 1999, 2003; Ramos-Gomez et al 1999). (Figures 1, 2 & 
3). 
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Fig. 1. Pseudomembranous candidiasis.  
 
 
Fig. 2. Pseudomembranous candidiasis.  
 
 
Fig. 3. Pseudomembranous candidiasis.  
4.1.2 Erythematous (atrophic) candidiasis 
This varies from diffuse to patchy redness throughout the oral mucosa. Multiple flat red 
patches of varying intensity occur. It sometimes presents as pinpoint to macular erythema, 
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which mimics a bleeding diathesis or submucosal trauma. They are most commonly located 
on the palate and the dorsum of the tongue. Non adherent filmy white to creamy plaques 
may be seen concurrently with this lesion. When the tongue is involved, there is selective 
loss of filiform papillae, resulting in a red, smooth to beaded mucosal surface.  
Median Rhomboid Glossitis is a specific type of erythematous candidiasis that presents as 
red, smooth, depapillated, persistent oral patch in the middle of the dorsum of the tongue. 
Tenderness or a burning sensation may be experienced. (Flaitz & Hicks 2003; Ramos-Gomez 
et al 1999). (Figures 4, 5 & 6) 
 
 
Fig. 4. Erythematous candidiasis.  
 
 
Fig. 5. Erythematous candidiasis.  
4.1.3 Angular cheilitis 
This presents as linear red or ulcerated fissures radiating from the corners of the mouth. 
They are typically bilateral, and multiple red papules may be found when the adjacent peri-
oral skin is involved. (Figure 7) It commonly occurs in conjunction with either of the other 
intraoral forms. (Flaitz & Hicks, 2003; Ramos-Gomez et al 1999) 
Diagnosis 
Definitive diagnosis of oral candidiasis is made from exfoliative cytological smears using 
PAS stain or potassium hydroxide or Gomori’s methenamine silver stain. Detection of  
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Fig. 6. Erythematous candidiasis (interdental papilla).  
fungal hyphae and/or pseudohyphae is necessary for microscopic diagnosis. Biopsy of the 
oral lesion can also be carried out. Fungal cultures are not usually necessary but are helpful 
in species identification when lesions are refractory to antifungal therapy. (Flaitz & Hicks 
1999, 2003).  
Treatment 
Candidiasis should be treated promptly and thoroughly with topical antifungal agents such 
as nystatin or clotrimazole. prognosis depends on disease severity, oesophageal 
involvement, recurrence rate, drug compliance, the child’s age and previous history and 
response to antifungal therapy. (Abrams 2000; Flaitz & Hicks 1999). Both oral and 
esophageal candidiasis have a high propensity to recur unless antifungal therapy is 
continued. Therapy is indicated to prevent the symptoms of pain, burning sensation, 
soreness and dysphagia that may occur. (Ramos-Gomez et al.,1999) 
Topical Antifungal Agents  
These include Nystatin, Ketoconazole, Clotrimazole, Amphotericin B and Miconazole.  
 Nystatin suspension (100,000U/ml) 100,000-500,000 U 6 hourly for 14days 
Oral pastille (200,000U)   6 hourly for 14 days 
 Clotrimazole troche (10mg)   10mg 4-5 times daily for 14days 
 Amphotericin B oral suspension (100mg/ml)  100mg 6 hourly for 14days 
 Miconazole oral gel (25mg/ml) 2. 5-5ml   6 hourly for 14 days 
 
 
Fig. 7. Angular cheilitis.  
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The long term use of these preparations may lead to increased incidence of caries because of 
their high dextrose or sucrose content. Topical fluoride should thus be prescribed. 
Alternatively, antifungal preparations designed for vagina use such as pessaries which 
contain less dextrose and sucrose may be used. (Greenspan 1994).  
Topical creams and ointments containing Nystatin, ketoconazole or Clotrimazole are used in 
the treatment of angular cheilitis and peri-oral skin or lip involvement. These are applied 3 
times daily. Angular cheilitis frequently occurs as a mixed infection with staphylococcus 
aureus, therefore an antibacterial ointment such as mupirocin may be indicated. A 
combination of a low potency steroid ointment and an antifungal is valuable when deep 
fissures and cracks on the lips are present. (the middle of the dorsum of the tongue. 
Tenderness or a burning sensation may be experienced. (Abrams 2000; Flaitz & Hicks 1999, 
2003; Greenspan 1993, 1994). Generally, antifungal therapy should be continued 1 to 2 weeks 
after clinical resolution of the lesions.  
Systemic Antifungal Agents  
These include Ketoconazole, Fluconazole and Itraconazole.  
 Ketoconazole tablets (200mg/tablets) 5-10mg/kg in 1 or 2 doses for 14days 
 Fluconazole suspension (50 or 200mg/5ml) 3-6mg/kg once daily to a maximum of 
100mg for 14 days 
 Fluconazole tablets (50 or 150mg/tab)    - as above-  
 Itraconazole caps (100mg/cap)  2-5mg/kg once daily for 14days  
 Itraconazole oral liquid (10mg/ml)   - as above- 
In cases of drug resistant candidiasis, microbiologic culturing may be important but 
Fluconazole and Itraconazole have been found to be more effective empirically for treating 
lesions resistant to other polyenes and azoles and are associated with longer disease free 
periods. Suppressive maintenance antifungal therapy is indicated when frequent episodes 
are encountered. (Flaitz & Hicks 1999, 2000)Disinfection and/or replacement of 
contaminated oral pacifiers, toothbrushes and orthodontic appliances should be done as 
these contribute to disease recurrence in children. Restoration of carious teeth and 
continuous caries prevention is important, as it has been shown microscopically that deep 
dental caries may act as a reservoir for Candida species in HIV infected individuals.  
(Jacob et al 1998) 
Recommended Prophylaxis Regimen (Flaitz & Hicks 1999) 
Nystatin oral suspension     100,000 to 400,000 units twice daily 
Clotrimazole     10mg twice daily 
Fluconazole    6mg/kg, once daily or weekly 
Chlorhexidine mouth rinse   twice daily 
4.2 Herpes simplex virus infection 
This is the most common viral muco-cutaneous disease affecting HIV-positive children. The 
majority of oral lesions are caused by herpes simplex virus type1 (HSV-1). Prevalence ranges 
from 2% - 24% in Paediatric HIV studies. HIV positive children who have two or more 
herpetic infection episodes within 1year are classified as having moderately symptomatic 
HIV disease. (Caldwell et al., 1994). There are 2 clinical forms: 
4.2.1 Primary herpetic gingivostomatitis  
This is a systemic viral infection which presents with sudden onset of fever, swollen and 
tender cervical lymph nodes, irritability and malaise. Classically, there is widespread 
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mucosal erythema, vesicles and painful coalescing ulcers. The gingiva, palate, dorsum of 
tongue, lip and the peri-oral skin are the commonest sites (Figures 8 &9). Excessive drooling 
of saliva and pharyngitis often accompanies this infection. Resolution usually occurs within 
14days but the disease may linger for several more weeks in immuno-compromised 
children. (William1993). 
 
 
Fig. 8. Primary herpetic gingivostomatitis.  
4.2.2 Recurrent herpes simplex virus infection 
This occurs when the Herpes simplex virus is reactivated within the trigeminal ganglion by 
factors such as excessive exposure to sunlight, physical injury, febrile systemic illness, 
immunosuppression, emotional stress and hormonal alterations. It is characterized by 
sudden onset of focal erythema, clustered vesicles and painful coalescing ulcers. The ulcers 
usually involve the vermilion border of the lip, peri-oral skin, and nasal mucosa and may 
form crusts extraorally. Intraorally, the gingivae and palatal mucosa are usually involved. 
Lesions typically heal within 7 – 10days.  
In immuno-suppressed children, lesions may be multifocal in distribution and occur on non-
keratinized mucosa. The infection may run a chronic course, lasting 4 - 6weeks and 
producing large crater form lesions with irregular serpentine to scalloped margins. Extraoral 
vesicular to crusted lesions that bleed on manipulation are characteristic. Deep persistent 
lesions may result in significant scarring. Cytomegalovirus co-infection has been observed 
in these persistent ulcers. (Flaitz et al., 1996). 
Some HIV and other immuno-compromised children develop an unusual disease pattern on 
the dorsum of the tongue called the geometric herpetic glossitis. This variant appears as 
multiple painful ulcerated fissures that radiate from the middle of the dorsum of the tongue. 
Herpetic lesions recur frequently in severe immunosuppression.  
Diagnosis of herpes simplex viral infection is usually clinical but can be confirmed in 
atypical lesions by exfoliative cytology, incisional biopsy or tissue culture with viral 
isolation or presence of viral giant cell. Immuno-cytochemical and fluorescent monoclonal 
antibody typing can be performed on direct smears, biopsy samples, or infected cells grown 
in tissue culture for more accurate diagnosis. (Flaitz & Hicks 1999). 
4.2.3 Treatment 
Most herpetic lesions in HIV infected children are reported to be self-limiting. Antiviral 
therapy is recommended in moderately to severely immuno-compromised children and in 
cases with frequent recurrences. Oral acyclovir is most frequently used. Lesions resistant to 
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acyclovir have been effectively managed with Foscarnet (Trisodium phosphonoformate 
hexahydrate).  
Acyclovir 200 – 400mg tabs  6 hourly for 10-14days 
Foscarnet 24 – 40mg/kg   8 hourly (very severe cases only) for 14-21days.  
Suppressive maintenance therapy may be indicated for children who develop multiple 
episodes. (Ramos-Gomez et al., 1999) 
 
 
Fig. 9. Primary herpetic gingivostomatitis.  
4.3 Linear gingival erythema (LGE) 
LGE is the most common form of HIV associated periodontal disease in HIV infected 
children. (Kline 1996, Ramos-Gomez et al 1999). The prevalence of LGE varies widely in 
different studies, ranging from 0-38%2. However, it appears to be more common in cohorts 
of adolescents aged 13-18 years than in younger children. (Barasch et al 2000; Howell et al 
1996).  
LGE presents as a fiery red, linear band 2 – 3mm wide on the marginal gingival 
accompanied by petechiae-like or diffuse red lesions on the attached gingival and oral 
mucosa. (Figure 10) The erythema may be accompanied by bleeding during brushing and in 
severe cases by spontaneous bleeding. It is most notable on the buccal surfaces from cuspid 
to cuspid. Pain is rarely an associated finding in most of these cases. (Ramos-Gomez et al 
1999). The degree of erythema is disproportionally intense compared with the amount of 
plaque that is present on the teeth. (Flaitz & Hicks 1999). 
Treatment 
Appropriate antifungal treatment is recommended because LGE represents an 
erythematous form of candidiasis. It is important to exclude neutropenia, 
thrombocytopenia, and plasma cell gingivitis in children with this condition. (Velegraki et al 
1999).  
There are no known criteria for definitive diagnosis of LGE but it resists conventional 
plaque removal therapies and oral hygiene measures and this distinguishes it from acute 
marginal gingivitis. LGE is now described as a candidal infection. Though the microbiology 
of LGE has not been fully described, C. albicans and C. dubliniensis have been isolated from 
LGE lesions in both children and adults. (Flaitz & Hicks 2003; Ramos-Gomez et al 1999; 
Velegraki et al 1999). 
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Fig. 10. Linear gingival erythema.  
4.4 Major salivary gland enlargement 
Salivary gland disease in HIV infected children presents as either xerostomia or major 
salivary gland enlargement. Major salivary gland enlargement refers to lymphocyte 
mediated salivary gland disease in cases of HIV infection. It may affect the parotid and/or 
submandibular glands. It was first seen in paediatric HIV infection. It is also called Diffuse 
Infiltrative Lymphocytosis syndrome or Sjogren syndrome-like disease. (Flaitz & Hicks 
2003). (Figure 11). 
Major salivary gland enlargement is more common in children than in adults with HIV 
infection and the prevalence in HIV infected children varies widely in different studies with 
up to 58% of them being affected. The aetiology of major salivary gland enlargement is 
unknown but infection with EBV or HIV or the interaction between these two viruses is 
suspected to be responsible. (Flaitz & Hicks 2003; Fonseca et al., 2000; Katz et al., 1993; 
Valdez et al., 1994).  
 
 
Fig. 11. Parotid gland enlargement.  
The parotid gland is most commonly affected with parotid swelling in 10 – 30% of HIV 
infected children. There is unilateral or bilateral diffuse soft tissue swelling resulting in 
facial disfigurement. It is sometimes painful, and may be associated with lymphoid 
interstitial pneumonitis and diffuse lymphadenopathy. There may be concurrent 
enlargement of the palatine tonsils, resulting in partial airway obstruction, difficulty with 
swallowing and sleep apnoea. Parotid swelling has been associated with slower progression 
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to AIDS: having a median time to death of 5. 4years as against 3. 4years among patients with 
oral candidiasis. (Chetty et al., 1999; Flaitz & Hicks 2003; Katz et al., 1993; Ramos-Gomez et 
al 1999). 
There are no established criteria for the definitive diagnosis of salivary gland enlargement 
(SGE) and the exact pathophysiology remains uncertain. Theories concerning the origin of 
SGE include lymphoepithelial lesions, cysts involving salivary parenchyma, interglandular 
lymph nodes, and an inflammatory infiltrate similar to Sjogren’s syndrome. Greenspan 
described the possible relationship between SGE and T-lymphocyte CD8+ cell infiltration in 
the gland. In addition, genetic loci have been linked to SGE in children, specifically 
HLADR5 and HLA-DR11, suggesting a genetic predisposition to this condition. (Greenspan 
& Greenspan 1996; Pinto& De Rossi 2004)  
Treatment 
Salivary gland swelling is usually left untreated because it is usually asymptomatic. 
However, there are a number of dental management concerns and serious complications in 
children related to infections of the salivary glands becoming life threatening at a faster rate 
than in adults. The paediatric dentist should be aware of the possible complications in the 
paediatric HIV/AIDS population. Often the salivary gland disorders or their potential 
sequelae can be a predictor of HIV disease progression. Consultation with the child's 
infectious disease provider, including ordering complete blood counts, should give an 
indication of the child's immune status. Assessment of salivary function should be 
performed at the initial dental exam. Subjective complaints of dryness in children are often 
equivocal, so the clinician should be familiar with examination of the Stensen’s and 
Wharton's ducts to verify flow. Palpation of the major glands and milking of the major 
glands should be a standard part of the comprehensive head and neck examination of the 
HIV Positive paediatric patient.  
Salivary gland disease can present as benign enlargement with or without xerostomia, 
xerostomia alone, or parotitis or more ominous conditions such as malignancy. In children, 
serious complications related to salivary gland infections can become life-threatening at a 
faster rate than in adults. The clinician should be aware of the etiologic agents that can cause 
parotitis (bacterial/viral). Knowledge of the child's immune status will often serve as a 
guide towards diagnosis (i. e., cytomegalovirus or paramyxovirus in immune-compromised 
children). Thorough examination of salivary ducts can provide valuable information on 
aetiology-(purulence in saliva, thick mucous saliva) and guide the clinician to adequate 
treatment. The antibiotic of choice is clindamycin, in a dosage of 8-25mg/kg/day. A 
therapeutic alternative antibiotic is penicillin, considering the gastrointestinal effects of 
clindamycin. (Pinto& De Rossi 2004).  
4.5 Recurrent aphtous ulcers (RAU) 
The prevalence of RAU in HIV infected children ranges from 0-7% similar to HIV infected 
adults. In general RAU tend to recur more frequently in the HIV infected child; and with 
immunosuppression, major aphthous ulcers are also more likely to develop. (Flaitz & Hicks 
2003).  
RAU presents as painful ulcers of rapid onset with marked predilection for non keratinised 
mucosa especially the labial and buccal mucosa, ventral tongue and soft palate. The 
pharyngeal and oesophageal mucosa may be involved in the most extensive cases. Three 
clinical varieties have been described based on size, number and duration of lesions present.  
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4.5.1 Minor recurrent aphthous ulcers 
This presents as 1-3 shallow, oval or round small ulcers less than 5mm in diameter covered 
with a pseudo membrane surrounded by an erythematous halo. (Figure 12). They are self 
limiting and typically heal within 2weeks without scarring. (Flaitz & Hicks 2003; Ramos-
Gomez et al 1999).  
 
 
Fig. 12. Minor Aphthous Ulcer.  
4.5.2 Major recurrent aphthous ulcers 
These are oval or round, similar to minor recurrent aphthous ulcers but much larger 1– 2cm 
in diameter, are fewer in number, and may persist for weeks at a time. They are painful and 
may interfere with mastication and swallowing. They tend to occur on the soft palate, buccal 
mucosa, tonsillar area, and tongue. They have well delineated to irregular borders and 
depressed bases and are often covered by a thick, tenacious, fibrinous exudate. Scaring is a 
common finding in this condition.  
4.5.3 Herpetiform recurrent aphthous ulcers 
These appear as clusters or crops of tiny recurrent aphthous ulcers, 1 to 2mm in diameter, 
which may coalesce. They tend to occur in the soft palate, buccal mucosa, tonsillar area, and 
tongue. Diagnosis is usually clinical, based on the size, site, appearance and duration of the 
ulcers.  
A definitive criterion for all three types of RAU is the response to treatment with steroid 
agents. Tissue cultures for viral, fungal and mycobacterial organisms and incisional biopsy 
are necessary for persistent lesions to rule out other causes of ulcers. (Flaitz & Hicks 2003; 
Ramos-Gomez et al 1999).  
4.5.4 Treatment 
A definitive criterion for all the three types is the response to treatment with steroid agents. 
Tissue cultures for viral, fungal and mycobacterial organisms and incisional biopsy are 
necessary for persistent lesions to rule out other causes of ulcers. Topical steroid therapy is 
the first choice. In severe cases, a short course of prednisolone is indicated. Antifungal 
agents to prevent oropharyngeal candidiasis are added when steroids are used. These 
steroids include fluocinomide, clobetasol propionate and dexamethasone elixir. (Ramos-
Gomez et al 1999).  
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5. Oral lesions less commonly associated with paediatric HIV infection 
5.1 HIV associated periodontal diseases  
These include: 
 Necrotising ulcerative gingivitis (NUG) 
 Necrotising ulcerative periodontitis (NUP) 
 Necrotising stomatitis (NS) 
In children, HIV associated periodontal diseases appear to be associated with both 
immunodeficiency and malnutrition4. HIV infected children from developing countries 
appear to be more susceptible to necrotising periodontal diseases. A declining immune 
system with CD4 + cell counts below 200 cells/mm is associated with necrotising ulcerative 
periodontitis and necrotising stomatitis. (Flaitz & Hicks 2003; Greenspan 1994; Ramos-
Gomez et al 1999).  
 
 
Fig. 13. Necrotising Ulcerative Periodontitis (NUP).  
5.1.1 Necrotising ulcerative gingivitis (NUG) 
This is uncommon in HIV infected children. It is reported to present with the destruction of 
one or more interdental papillae accompanied by necrosis, ulceration and/or sloughing. 
Destruction is limited to the marginal gingival tissues. In the acute stage, the gingival tissues 
appear fiery red and swollen, and is accompanied by yellowish grey necrotic tissue that bleeds 
easily. Patients are reported to experience bleeding on brushing, pain and a characteristic 
halitosis. Symptoms subside gradually over 3 – 4 weeks but recurrences are common.  
There may be lymphadenopathy, fever and malaise. Permanent gingival scarring with 
interdental papillary crater contributes to an increased risk of recurrence. (Flaitz & Hicks 2003).  
Diagnosis is based on clinical features described above.  
5.1.2 Necrotising ulcerative periodontitis (NUP)  
NUP has been reported in 0-4% of children. It presents as severe soft tissue necrosis along 
with destruction of the periodontal attachment and bone over a short period of time. 
Patients often experience spontaneous gingival bleeding or bleeding when brushing and 
severe, deep, aching pain in the jawbone. The jawbone may be exposed in the most severe 
www.intechopen.com
 Oral Manifestations of Paediatric HIV Infection 181 
cases. The final stage of NUP is marked by severe gingival recession resulting from rapid 
bone loss and soft tissue necrosis. (Figures 13 &14) Pocketing may be minimal and tissue 
destruction may extend across the mucogingival junction. The more extensive disease may 
contribute to premature exfoliation of primary teeth and aborted development or early loss 
of primary teeth. (Flaitz & Hicks 2003; Ramos-Gomez et al 1999). Diagnosis of NUP is based 
on clinical presentations.  
 
 
Fig. 14. Necrotising Ulcerative Periodontitis (NUP) 
5.1.3 Necrotising stomatitis (NS) 
This presents as an acute and painful ulceronecrotic lesion on the oral mucosa. The lesion 
starts from the oral mucosa and may extend to alveolar bone and contiguous soft tissues. 
The underlying bone may be exposed. Histologic examination reveals the features of non-
specific ulceration. No specific microbial organism has been identified as the cause of NS. 
(Flaitz & Hicks 2003; Ramos-Gomez et al 1999).  
5.1.4 Treatment for NUG, NUP and NS 
Local treatment 
 Gentle debridement of affected areas to minimize bleeding and pain 
 Irrigation with 10%Betadine providone -iodine or 1:4 hydrogen peroxide or 
Chlorhexidine gluconate (Peridex), 0. 12% to aid debridement.  
 Oral hygiene instruction  
Systemic Treatment  
 Metronidazole (Flagyl) 125 mg tablets 8hourly for 7days 
 Amoxicillin (Amoxil) 250 mg 8hrly for 7days  
If the patient is allergic to penicillin: 
 Erythromycin enteric coated 250mg tablet 8hourly for 7 days  
The patient should be re-evaluated after one week of treatment and the medication should 
be repeated if response is not satisfactory.  
Supportive therapy: Multivitamins 
5.2 Viral infections 
5.2.1 Human Papilloma Virus 
Human Papilloma Virus (HPV) induced oral lesions associated with HIV infection include 
Verucca vulgaris, condyloma acuminatum, focal epithelial hyperplasia, and koilocytic 
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dysplasia which are referred to as oral warts. Oral HPV infections are rare in children. Oral 
warts present as raised, irregular, flesh coloured lesions.  
5.2.2 Focal epithelial hyperplasia (Heck’s disease) 
This is a benign condition associated with HPV types 13 and 32 and is usually seen in 
children. The lesions appear as multiple, non-tender papules, plaques or nodules with 
grainy pink mucosal surfaces. The labial, buccal and lateral tongue, mucosa are most often 
involved, with occasional lesions on the palatal and gingival mucosa. (Figure 15). 
Treatment 
In most cases, conservative excision is treatment of choice. Other methods of treatment 
include laser ablation, topical podophyllin resin, systemic interferon, and cimetidin. Despite 
aggressive therapy and multiple treatment modalities, recurrences are common when oral 
warts are widespread. (Flaitz & Hicks 2003; Howell et al 1996; Ramos-Gomez et al., 1999).  
 
 
Fig. 15. Focal Epithelial hyperplasia (Heck's disease).  
5.2.3 Verruca vulgaris 
This typically affects the skin, especially the hands and perioral skin. Oral mucosal 
involvement due to inoculation from these extraoral sites. Intraoral involvement is 
uncommon and is usually limited to isolated areas of the lip vermillion, labial mucosa and 
anterior tongue. They present as white, rough, conical or papillary papules or nodules. 
Treatment is as for Focal Epithelial Hyperplasia above.  
5.2.4 Condyloma acuminatum 
It typically presents as a large sessile, pink nodule with short, blunt surface projections. 
Multiple lesions may be found that tend to coalesce, forming a discrete, well-delineated 
enlargement. Diagnosis is usually clinical. Definitive diagnosis can be made by excisional 
biopsy.  
Treatment is as for Focal Epithelial Hyperplasia and oral warts.  
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5.2.5 Cytomegalovirus (CMV) 
This presents as a persistent oral ulcer, which may mimic aphthous ulcers, recurrent herpes 
simplex virus infection, necrotising stomatitis and ulceration not otherwise specified. 
Occasionally it may present as a brightly erythematous gingivitis. CMV ulcers in the oral 
cavity usually occur with disseminated CMV disease; therefore the patient should be 
examined for the systemic disease or other organ involvement including CMV retinitis, 
colitis, pneumonitis and progressive neurologic disease. Definitive diagnosis can be made 
through culture and biopsy. (Flaitz et al., 1996; Ramos-Gomez et al., 1999).  
5.2.6 Varicella Zoster Virus (VZV) 
VZV infection can present as Herpes Zoster or Varicella (chicken pox). HIV infected children 
are at risk for persistent, recurrent, chronic infections with VZV. Children with advanced 
immunosuppression seem to be at increased risk for recurrent disease and more severe 
manifestations of VZV. Chronic VZV infection has been described in HIV-infected children 
and adults with low CD4+ counts. (Gershon et al., 1997; Morris et al., 1996; Ramos-Gomez et 
al., 1999).  
5.2.7 Herpes Zoster 
The Center for Disease Control and Prevention has classified an HIV-infected child with 
herpes zoster involving at least 2 distinctive episodes or more than one dermatome as being 
moderately symptomatic. Herpes Zoster infection results from a reactivation of latent varicella 
– zoster virus. Fevers, complaints of sensitive teeth, earache or headache as well as pain or 
paresthesia are prodromal symptoms. A well-delineated unilateral maculo-papular rash that 
becomes pustular ulcerated follows. Involvement of the second and third branches of the 
trigeminal nerve produces oral lesions on both keratinised and non keratinsed oral mucosa 
that extend to the midline. Frequently concurrent vesicles and crusted skin lesions overlie the 
affected dental quadrant. Most cases heal without complications in children except for facial 
skin scarring. Definitive diagnosis is by virus antigen typing with laboratory immunologic 
tests. (Caldwell et al., 1994; Flaitz & Hicks 2003; Ramos-Gomez et al 1999).  
5.2.8 Molluscum contagiosum 
This is a virally induced lesion of the skin, vagina, and rarely, the oral cavity. Lesions are 
small, discrete, and dome shaped. Their colour ranges from pearly white to skin colour. The 
lesions may number in the hundreds. Definitive diagnosis is made when molluscum bodies, 
which are virally transformed epithelial cells are seen, when the core of the lesion is 
expressed and stained.  
(Ramos-Gomez et al 1999).  
5.3 Xerostomia 
Xerostomia is a common symptom of HIV-infected individuals and has many potential 
causes.  
It is more common in HIV infected children than HIV-infected adults. The causes of 
xerostomia include HIV infection itself, therapeutic antiviral and antimicrobial drugs, 
prophylactic medications, antiretrovirals (such as didanosine), gamma globulin, or 
lymphocytic infiltration of the major salivary glands. Clinical features include dry mouth 
(Figure 16) and severely reduced salivary flow rates. Reduced salivary flow results in a 
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mucosa that is desiccated and is at higher risk for opportunistic infections such as 
candidiasis and increased caries. Xerostomia may appear with or without parotid swelling. 
No definitive diagnostic criteria exist for xerostomia. (Flaitz & Hicks 2003; Frezzini et al., 
2006; Ramos-Gomez et al 1999).  
 
 
Fig. 16. Dry lips with crusting, resulting from xerostomia.  
6. Oral lesions strongly associated with HIV infection but rare in children 
6.1 Kaposi’s sarcoma 
This is much less common in HIV infected children than adults. The incidence of HIV 
associated cancers in symptomatic children is less than 2%. However, among HIV infected 
paediatric population, it is more common in Africa, Latin America and Eastern Europe, 
where endemic Kaposi's sarcoma is more prevalent in the non-HIV infected population. 
Human herpes virus – 8 has been identified in all forms of Kaposi's sarcoma. (Flaitz & Hicks 
2003; Ramos-Gomez et al 1999; Ranganathan & Hemalatha 2006). Kaposi’s sarcoma presents 
as one or more erythematous, slightly bluish or violaceous macules or swellings with or 
without ulceration. It is predominantly seen on the palate or gingiva. A definitive criterion is 
characteristic histologic appearance on biopsy. (William 1993).  
6.2 Non-Hodgkin’s lymphoma  
This is far less common in HIV infected children than adults. This presents as a firm, elastic 
often somewhat reddish or purplish swelling with or without ulceration. The gingiva, palatal 
mucosa and fauces are more commonly affected. A definitive criterion is the characteristic 
histological appearance on biopsy, supported by appropriate immuno-cytochemical or 
molecular biological investigations. (Ramos-Gomez et al 1999; William 1993).  
6.3 Oral Hairy Leukoplakia (OHL) 
This is an opportunistic infection caused by the Epstein-Barr virus (EBV) and is a marker for 
increasing immunodeficiency. It is a common oral manifestation of HIV infection in adults 
with a point presence of approximately 20% but it is documented in only 2% of children 
infected with HIV. It presents as white non-removable lesions with corrugated surface 
appearing bilaterally on the lateral border of the tongue. These lesions may appear on the 
ventral and dorsal surfaces of the tongue and more rarely, on the buccal mucosa. Definitive 
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criteria for oral hairy leukoplakia are the presence of Epstein –Barr virus (EBV) in the 
lesions, to be determined by laboratory histopathology and in-situ DNA hybridization. 
(Flaitz & Hicks 2003; Morris et al., 1996; Ramos-Gomez et al 1999).  
6.4 Tuberculosis related ulcers 
A combined infection with HIV and mycobacterium tuberculosis is common in LINCs and 
developing countries. However, secondary and primary tuberculosis lesions of the oral 
cavity are rare. The lesions present as painless, non-healing ulcerations on the buccal 
mucosa, hard palate, gingivae and/or tongue. Occasionally, tuberculosis may present with 
tongue involvement manifesting as macroglossia or a mass in the cheek. In most cases the 
mucosal lesions are difficult to recognize, but enlarged regional lymph nodes may call 
attention to the process.  
A chest radiograph and a Purified Protein Derivative test with appropriate controls should 
be obtained. Diagnosis is usually confirmed by identification of acid-fast bacilli in tissue 
sections or culture. The oral lesions respond to treatment with use of anti-tuberculosis 
drugs. (Ceballos-Selobrena et al., 1996; Grupta et al., 1997; Hathiram et al., 1997; Haller & 
Ginsberg 1997; Kolokotronis et al., 1996; Ramesh 1997; Phelan et al., 1997; Ramos-Gomez et 
al 1999).  
7. Oral conditions with increased severity in paediatric HIV infection 
7.1 Gingivitis and periodontitis (increased gingival and plaque indices) 
Gingival disease not specifically associated with HIV infection is called conventional 
gingivitis. Reported prevalence in HIV infected children is 7% and 40%. Clinically, it 
presents as gingival inflammation in the absence of attachment loss, necrosis or gingival 
erythematous banding.  
(Barasch et al., 2000; Gelbier et al., 2000). An association between the prevalence of gingivitis 
in HIV infected children and age has been reported. (As low as 6% in less than 1 year olds, 
55% in 1year olds, 85% in 2year olds, 87% in 3year olds and 66% in 4year olds). (Ramos et 
al., 2000).  
7.2 Over retained primary teeth and delayed eruption of primary and permanent teeth 
Delayed eruption of teeth has been reported among children with HIV-infection. Poor 
general health in some children may be an associated factor. Delayed tooth development has 
been reported in 31% of paediatric AIDS patients. (Valdez et al 1994). Delayed dental 
development in paediatric HIV patients has been linked to lower CD4 counts. In the report 
by Ramos-Gomez et al 2000; it was observed that at age 3, there was an average of two fewer 
teeth per child among children whose average CD4 count was 200/mm3 than children 
whose average CD4 count was 800/mm. A study on 173 HIV infected children, delayed 
eruption was reported in 43% males and 41% females. Accelerated eruption in 11% males 
and 13% females, while 46% of both males and females have normal eruption pattern. Over 
retained primary teeth was observed in 25% of the children. (Flaitz et al., 2000).  
7.3 Dental caries 
There is anecdotal evidence of vulnerability of HIV infected children to dental caries. 
However, some researchers have drawn attention to comparable caries prevalence in 
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infected and non-infected children. Other studies have shown slightly higher prevalence of 
dental caries in children with HIV. The suggestion that caries development could be directly 
linked to immunosuppression is yet to be substantiated, although the possibility does exist. 
Other factors may be responsible for the high caries level in these children, and these 
include infant feeding practices, the long term use of sugar containing medicines, high 
consumption of carbohydrate and sugar intake required to prevent or treat any failure to 
thrive.  
A number of studies have reported on the prevalence of dental caries among HIV infected 
children. (Elderidge & Gallagher 2000; Flaitz et al., 2000; Gelbier et al., 2000; Hicks et al 2000; 
Obileye et al., 2009, Sowole et al 2009; Tofsky et al 2000; Valdez et al 1994). In a study on 
dental caries prevalence and dental health behavior in HIV infected children, 63% of the 
children had past dental caries experience. (Elderidge & Gallagher 2000) This is similar to a 
previous report by Valdez et al; it was observed that 60% of paediatric AIDS patients had 
clinical evidence of current or past caries.  
In the primary dentition of HIV infected children, the anterior caries (early childhood caries, 
nursing bottle or baby bottle tooth decay) pattern is common. The pattern of caries observed 
in this group of children may be as a result of poor oral hygiene practices, inappropriate use 
of a nursing bottle containing high sucrose liquids at bed time, medications containing high 
sucrose content, xerostomia induced by medication or HIV infection, the need for high 
caloric and carbohydrate/sucrose diets, and alterations in saliva viscosity, cytokines, 
protease inhibitors and immunoglobulin. (Flaitz & Hicks 2003). (Figures 17 & 18) 
 
 
Fig. 17. Dental caries on mandibular primary molars.  
 
 
Fig. 18. Dental caries on maxillary primary canines and molars.  
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Dental caries status in primary dentition of HIV infected children has been reported to be 
considerably greater than that for the United States paediatric population. (Hicks et al., 2000.) 
During the 30 month period longitudinal study, there was an almost two fold increase in 
primary tooth surface caries for the 2-9 year olds. Caries free status in the primary dentition 
declined from 60% at baseline to 37% at the 30months period. Among 5 to 11 year olds, dmfs 
and dmft remained relatively stable while the proportion of caries free individuals declined 
from 72% at baseline to 50% at 18 months. Caries free status decreased with age, lower CD4 
percentage and from moderate to severe immunosuppression. (Hicks et al., 2000). A high 
prevalence of Candida colonization in HIV positive /AIDS children with untreated dental 
caries has been reported. (Domaneschi et al., 2010). This further reinforces the importance of 
oral health care in interdisciplinary health unit that manage these patients.  
Caries and periodontal disease are among the most common infections known to humans. 
Both are initiated by oral bacteria and are modulated by the host response. Disease occurs as 
a result of an imbalance between the provoking bacteria and host response. It is logical to 
expect, therefore, that alterations of either the associated aetiological factors or the host 
response to these factors and or agents should result in a change in the clinical presentation 
of disease. (Fine et al., 2003). 
8. Conclusions 
Oral manifestations are common and prevalent in paediatric HIV infection and have been 
found to be the earliest indicators of HIV infection. Early intervention in HIV disease is 
crucial for each individual according to his/her risk and seroconversion status. 
Comprehensive oral examination should be done at regular intervals especially in LINCs 
and developing countries where techniques to diagnose, and the drugs to treat HIV 
infection are not uniformly distributed. The use of oral lesions as predictors of disease 
progression could be of immense importance. Primary oral health care for HIV infected 
children should include a careful oral examination at regular intervals to ensure early 
detection and intervention for pseudomembranous candidiasis and other infections and to 
prevent more deterioration of the immune system and further opportunistic infections. 
Preventive oral health care especially where treatment is progression unavailable, can 
improve a child's overall health. Though these measures cannot stop HIV disease 
progression, in the absence of medications, improved diagnosis of the oral manifestations 
can enhance case management, ensure better oral health outcomes, reduce morbidity and 
improve quality of life of HIV-infected children.  
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